Fudan University clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 1,308 studies whose lead sponsor is Fudan University. 637 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Fudan University studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Where
- China
- 1,144
Focus areas
Conditions Fudan University leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Breast Neoplasms260Colorectal Neoplasms118Carcinoma94Triple Negative Breast Neoplasms66Neoplasm Metastasis65Stomach Neoplasms56Carcinoma, Non-Small-Cell Lung51Pancreatic Neoplasms49Carcinoma, Hepatocellular46Rectal Neoplasms38Esophageal Squamous Cell Carcinoma37Lung Neoplasms32Neoplasms32Carcinoma, Squamous Cell28Esophageal Neoplasms28Liver Neoplasms28Adenocarcinoma27Lymphoma27Nasopharyngeal Carcinoma27Prostatic Neoplasms20Brain Neoplasms16Cholangiocarcinoma15Thyroid Neoplasms15Sarcoma14
Studies
Recruiting first, then most recently updated. Showing 50 of 1,308. Browse all 1,308 →
- Reverse Triple Negative Immune Resistant Breast CancerRecruitingNCT05076682Phase 2
- First-line Treatment With Dual Immunotherapy Combined With Anti-angiogenesis for Unresectable Advanced Malignant Peritoneal MesotheliomaNot yet recruitingNCT07893340Phase 2
- G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell TransplantationRecruitingNCT07362810Phase 2
- Thymalfasin Combined With Chemotherapy and Immunotherapy in TNBC Neoadjuvant TreatmentNot yet recruitingNCT07884201Phase 2
- Becotatug Vedotin Plus Pucotenlimab for Metastatic Colorectal CancerRecruitingNCT07884188Phase 2
- Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal CancerRecruitingNCT06841159Phase 2
- Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSSNot yet recruitingNCT07877597Phase 3
- A Phase II Study of Ipilimumab N01 Plus Sintilimab for MSI-H or dMMR Gastric and Gastroesophageal Junction CancerNot yet recruitingNCT07878221Phase 2
- Retlirafusp Alfa Combined With Zeprumetostat, Apatinib, and Chemotherapy as First-Line Treatment for Metastatic GC/GEJCNot yet recruitingNCT07874425Phase 2
- Artificial Intelligence-assisted Primary Care for Influenza Vaccination Among Chronic Patients in China (AIPC-Flu)Not yet recruitingNCT07873255Not applicable
- FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)RecruitingNCT07815834Phase 3
- Artificial Intelligence-assisted Primary Care for RSV Prevention (AIPC-RSV) in ChinaNot yet recruitingNCT07856290Not applicable
- Family Physician Nudges for Influenza Vaccination Among Older AdultsNot yet recruitingNCT07864597Not applicable
- Hemodynamic Characteristics of Peripheral Arterial Disease Using Computational Fluid DynamicsNot yet recruitingNCT07860138
- Vaccine Knowledge, Attitudes and Practices Among Men Who Have Sex With Men: a Global Cross-sectional StudyNot yet recruitingNCT07856563
- SHR-A1811 Versus Trastuzumab Plus Pertuzumab in ctDNA-Positive HER2-Positive Early Breast Cancer After Pathologic Complete ResponseNot yet recruitingNCT07856303Phase 2
- Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast CancerRecruitingNCT06637150Phase 3
- Cryoablation Combined With Anlotinib Plus TQB2868 in Patients With Advanced Intrahepatic CholangiocarcinomaNot yet recruitingNCT07846267Phase 2
- Capecitabine in Low Risk Triple Negative Breast CancerRecruitingNCT06787339Phase 2
- TCb vs EC-T in High Risk ER+/HER2- Breast CancerRecruitingNCT05901428Phase 3
- T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain MetastasisRecruitingNCT07152782Phase 2
- CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon)RecruitingNCT07432178Phase 3
- T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain MetastasisRecruitingNCT07150208Phase 2
- Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast CancerNot yet recruitingNCT07419880Phase 2
- 1-Week Versus 3-Week PBIRecruitingNCT07832279Not applicable
- Exploring the Impact of Diurnal Variation on Coagulation Function in Patients Undering Tumor SurgeryEnrolling by invitationNCT07841613
- ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon CancerRecruitingNCT07841236Phase 2
- Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic TherapyRecruitingNCT07829848Not applicable
- SCRT Combined With CAPOX and PD-1/CTLA4 Antibody for Early-stage Low Rectal CancerNot yet recruitingNCT07837362Phase 2
- Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based ReconstructionRecruitingNCT07835139Not applicable
- Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 StudyRecruitingNCT07132463Phase 3
- Cryoablation Combined With QL1706 (Iparomlimab/Tuvonralimab) Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer.Not yet recruitingNCT07829874Phase 2
- A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile CancerRecruitingNCT07497919Phase 2
- Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast CancerNot yet recruitingNCT07825753Phase 2
- Chemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- Breast CancerNot yet recruitingNCT07826052Phase 2
- Consolidative Stereotactic Radiotherapy for Oligo-Residual Advanced EGFR-Mutant NSCLC After First-Line Third-Generation EGFR-TKI Plus ChemotherapyNot yet recruitingNCT07822984Phase 2
- Clinical Value of CT Perfusion in Peripheral Artery DiseaseNot yet recruitingNCT07816757
- MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary CarcinomasNot yet recruitingNCT07816770Phase 2
- The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung CancerRecruitingNCT06738160Phase 2
- Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLCRecruitingNCT07554846Phase 3
- HER2-PET: Predicting T-DXd Efficacy and HER2 HeterogeneityRecruitingNCT07586215
- Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.RecruitingNCT07638852Phase 2
- A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver SpreadNot yet recruitingNCT07256223Phase 2
- Station 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLCRecruitingNCT07801430Not applicable
- Total Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal CancerNot yet recruitingNCT07810114Phase 2
- Olive Oil Before Lung Cancer Surgery to Prevent ChylothoraxRecruitingNCT07807696Not applicable
- AI-Assisted Patient Support in mHSPCNot yet recruitingNCT07804030Not applicable
- Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast CancerRecruitingNCT06649331Phase 2
- Immediate Autologous Tissue Breast Reconstruction and Radiotherapy Strategy After Breast Cancer SurgeryEnrolling by invitationNCT07798466
- Correlation Between Artificial Intelligence-Based Fecal Coverage Area-Quantified Bowel Preparation Quality Score (FQ-BBPS) and Adenoma Detection RateNot yet recruitingNCT07795788